Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Farehin Khan"'
Autor:
Joshua A Hayden, Vilma Zigmantaite, Chase A. Mazur, Ramune Grigaleviciute, Michael J. Satlin, Ruta Petraitiene, Thein Aung, Ethan Naing, Thomas J. Walsh, Vidmantas Petraitis, Audrius Kučinskas, Bo Bo Win Maung, Rimantas Stakauskas, Povilas Kavaliauskas, Benjamin Georgiades, Farehin Khan
Publikováno v:
Antimicrob Agents Chemother
Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) is an emerging global public health threat that causes life-threatening pneumonia and bacteremia. Ceftazidime-avibactam (CZA) represents a promising advance for the treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fa3d585c38c183ad00f344139f86ac3
https://doi.org/10.1128/aac.02157-19
https://doi.org/10.1128/aac.02157-19
Autor:
Douglas S. Scherr, Padraic O'Malley, Daniel P. Nguyen, David M. Golombos, Patrick Lewicki, Farehin Khan
Publikováno v:
Journal of Urology. 196:1390-1396
Peritoneal carcinomatosis and extrapelvic lymph node metastases can be seen following robot-assisted radical cystectomy. In an attempt to identify predictors of these atypical metastases we report a detailed analysis of patients treated with robot-as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83aec18c7c629c58f0673465d4c9df3b
https://doi.org/10.1016/j.juro.2016.05.101
https://doi.org/10.1016/j.juro.2016.05.101
Autor:
Daniel P. Nguyen, Farehin Khan, Savanah Brooks, Douglas S. Scherr, Padraic O'Malley, Brandon Otto
Publikováno v:
BJU International. 118:437-443
Objective To determine the safety of robot-assisted cystectomy (RAC) in patients with an irradiated pelvis, by comparing perioperative complication outcomes after RAC in patients with and without a history of pelvic irradiation. Patients and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24180154f34617c95140b615c9e74fec
https://doi.org/10.1111/bju.13464
https://doi.org/10.1111/bju.13464
Autor:
Melanie Olesky, Abdul Mutlib, Ruta Petraitiene, Ravi S Singh, Bo Bo Win Maung, Thomas J. Walsh, Ieva Alisauskaite, Harmut Derendorf, Farehin Khan, Xiaoyun Niu, Michael J. Satlin, Vidmantas Petraitis, Joseph V. Newman
Eravacycline (7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline or TP-434) is a novel, fully synthetic broad-spectrum fluorocycline with potent activity against Gram-positive bacteria, anaerobes, and multidrug-resistant Enterobacteriacea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef5d28c169f8e1b863c7a435dde9bfd8
https://europepmc.org/articles/PMC6125520/
https://europepmc.org/articles/PMC6125520/
Autor:
Chase A. Mazur, Joshua A Hayden, Benjamin Georgiades, Michael J. Satlin, Farehin Khan, Thomas J. Walsh, Bo Bo Win Maung, Ruta Petraitiene, Vidmantas Petraitis
Publikováno v:
Open Forum Infectious Diseases
Background CRE have been identified by the CDC as one of three urgent antibiotic resistance threats. The international emergence of these pathogens has largely been driven by the dissemination of carbapenemase-producing Klebsiella pneumoniae (KPC-Kp)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89762c26cc6ba420cb6b06234af1d400
https://doi.org/10.1093/ofid/ofx163.660
https://doi.org/10.1093/ofid/ofx163.660